So far this year, influenza cases are nearly 20 per cent higher than they were last year, and 2,800 cases were recorded in ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...

Since the 2017 acquisition of Patheon, the company has been part of Thermo Fisher, one of the largest life sciences companies ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Moderna said on Monday its experimental influenza vaccine showed superior efficacy compared with a licensed standard-dose ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

U.S. Health Secretary Robert F. Kennedy Jr’s newly appointed Advisory Committee on Immunization Practices (ACIP) upheld ...